S

Sirajudeen

Active Director Director DIN 11385281
DIN 11385281 First appointment Nov 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2025
Shareholding value Locked Premium profile

About Sirajudeen

Sirajudeen has experience in corporate governance. Holds Director role. Currently with 1 company, including Medfidus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11385281
Primary Designation Director
First Appointment 21 Nov 2025
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Director 21 Nov 2025 Not Provided Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medfidus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sirajudeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sirajudeen

Sirajudeen has experience in corporate governance. Holds Director role. Currently with 1 company, including Medfidus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sirajudeen is associated with 1 company as Director.

Sirajudeen has expertise in General Business.

Sirajudeen has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available